Related Experiment Video
Updated: Jul 14, 2026

Pressure Controlled Ventilation to Induce Acute Lung Injury in Mice
Published on: May 5, 2011
Role of ERK1/2 signaling pathways in 4-aminopyridine-induced rat pulmonary vasoconstriction
Weina Han1, Xiaobo Tang, Hong Wu
1College of Pharmacy, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, Heilongjiang 150081, P.R. of China.
Abstract:
The aim of the present study was to investigate the contribution of extracellular signal regulated kinase-1/2 (ERK1/2) to pulmonary artery contraction in response to 4-aminopyridione (4-AP), an inhibitor of a voltage-gated K(+) channels that regulate pulmonary vascular tone. Pulmonary artery rings 1-1.5 mm in diameter from male adult Wistar rat were isolated and cut into 3-mm in length. ERK1/2 up-stream kinase (MEK) inhibitors 2'-amino-3'-methoxyflavone (PD98059) and 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio)-butadiene (U0126), which block the activation of ERK1/2, were used to test the role of ERK1/2 in 4-AP induced pulmonary arterial vasoconstriction and the influences of 4-AP on expressions of phosphorylated ERK1/2 (p-ERK1/2) in cultured rat pulmonary arterial smooth muscle cells (PASMCs) and whole tissues. Our results show that 4-AP elicited concentration-dependent increases in tension of rat pulmonary artery rings, effects that were reduced by pretreatment of the rings with ERK inhibitors, PD98059 (20 microM) and U0126 (10 microM). Moreover, 4-AP increased the expressions of p-ERK1/2 in cultured PASMCs s and whole tissues, which were prevented by pretreatment of the cells or tissues with U0126. These results indicate that ERK1/2 signaling pathway contributes to pulmonary vasoconstriction induced by 4-AP.
Insights
Extracellular signal regulated kinase-1/2 (ERK1/2) signaling contributes to pulmonary artery contraction caused by 4-aminopyridione (4-AP). Inhibiting ERK1/2 reduces 4-AP-induced vasoconstriction and phosphorylation of ERK1/2 in pulmonary artery smooth muscle cells.
Area of Science:
- Cardiovascular Physiology
- Molecular Biology
- Pharmacology
Background:
- Pulmonary vascular tone is regulated by voltage-gated K(+) channels.
- 4-aminopyridione (4-AP) inhibits these channels, affecting pulmonary artery contraction.
- The role of extracellular signal regulated kinase-1/2 (ERK1/2) in this process requires elucidation.
Purpose of the Study:
- To investigate the contribution of the ERK1/2 signaling pathway to pulmonary artery contraction induced by 4-AP.
- To examine the effect of 4-AP on the expression of phosphorylated ERK1/2 (p-ERK1/2) in pulmonary arterial smooth muscle cells (PASMCs) and tissues.
Main Methods:
- Isolated rat pulmonary artery rings were used to measure tension changes.
- ERK1/2 inhibitors (PD98059, U0126) were employed to block ERK1/2 activation.
- Western blotting was used to assess p-ERK1/2 expression in PASMCs and whole tissues.
Main Results:
- 4-AP caused a concentration-dependent increase in pulmonary artery ring tension.
- Pretreatment with ERK1/2 inhibitors PD98059 and U0126 significantly reduced 4-AP-induced vasoconstriction.
- 4-AP increased p-ERK1/2 expression in PASMCs and tissues, an effect blocked by U0126.
Conclusions:
- The ERK1/2 signaling pathway plays a significant role in mediating pulmonary vasoconstriction induced by 4-AP.
- These findings highlight ERK1/2 as a potential target for modulating pulmonary vascular tone.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
MAPK Signaling Cascades
Nitric Oxide Signaling Pathway

